Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
SureNano Science Ltd. has completed the acquisition of GlucaPharm Inc., enhancing its pharmaceutical capabilities. This acquisition allows SureNano to strengthen its position in the rapidly growing GLP-1 drug market. GlucaPharm's GEP44 is a promising candidate aimed at treating obesity with improved delivery options. The deal was structured as a share exchange, issuing millions of shares to GlucaPharm shareholders.
Company Information
Company
SureNano Science Ltd
Location
Vancouver, British Columbia, Canada
About
SureNano Science Ltd. is a biotechnology company focused on advancing drug delivery systems. The company aims to develop next-generation therapeutics, improving performance and patient experience. SureNano's research is directed towards innovative solutions in the pharmaceutical market.
Predictive Intelligence
Strategic
ML-powered predictions for SureNano Science Ltd's next move
Vancouver
PuneBiotechnologyHealth CarePharmaceuticalReal EstateConstruction